Postpartum hemorrhage in a Jehovah's Witness patient controlled with Tisseel, tranexamic acid, and recombinant factor VIIa.
Abstract
BACKGROUND
The management of a patient refusing blood transfusion who subsequently experiences a severe postpartum hemorrhage is a particular
clinical challenge.
CASE
A 30-year-old nulliparous patient (who was a Jehovah's Witness) had labour induced for post-dates at 41+4 weeks' gestational
age after an uncomplicated pregnancy. She delivered by Caesarean section for dystocia and suspected chorioamnionitis, and
subsequently developed postpartum hemorrhage that required management with oxytocin, ergometrine, carboprost, uterine artery
ligation, and Hayman compression sutures. The patient ultimately required two additional visits to the operating room, culminating
in hysterectomy. Use of tranexamic acid, recombinant factor VIIa, and Tisseel was instrumental in halting the ongoing hemorrhage.
CONCLUSION
Optimal management of a patient refusing administration of blood products requires a multidisciplinary approach as well as
a combination of traditional and novel therapies.
Authors
Arab TS, Al-Wazzan AB, Maslow K
Institution
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Manitoba, Winnipeg, MB.
Source
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstétrique et gynécologie du Canada : JOGC 32:10 2010 Oct pg 984-7MeSH
AdultAntifibrinolytic Agents
Factor VIIa
Female
Fibrin Tissue Adhesive
Hemostatics
Humans
Hysterectomy
Jehovah's Witnesses
Postpartum Hemorrhage
Pregnancy
Recombinant Proteins
Tranexamic Acid
Uterine Artery
Pub Type(s)
Case ReportsJournal Article
Language
eng
PubMed ID
21176309
Log In

